VISIGN Upside Potential On the upside potential, GoodRx could sign a major corporate or insurance partner similar to the Kroger deal that would provide a pool of continuous customers. This would have to go hand in hand with strong execution on all current strategies, as they need to double the market and then grow on top of that. As discussed above, upside potential is mitigated by industry headwinds that I don't believe management has fully considered in the long-term guidance range. I am updating my analy ...

First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today a patient affordability initiative to provide citrate-free Adalimumab-adbm, Boehringer's biosimilar to Humira® (adalimumab), at a low cash price available exclusively on GoodRx. This program is a significant step in addressing access and affordab ...

Source: JPstock / Shutterstock.com A pending or ongoing lawsuit isn't always a reliable indicator of stocks to sell, but, in many cases, investors should take litigation as a sign to dig beneath the surface. Source: II.studio / Shutterstock.com Still, these stocks to sell combine the worst of both worlds: They're facing ongoing lawsuits, and in each of the three cases, the stock itself is a stinker. GoodRx (NASDAQ:GDRX) is facing a fresh lawsuit claiming the company misrepresented Kroger's (NYSE:KR) total c ...

The cost of prescription medications in the U.S. has increased by 37% since 2014, far surpassing the rate of inflation, according to data from drug savings company GoodRx. On average, Americans pay 2 to 3 times more for prescription drugs than consumers in other developed countries, according to the White House. — CNBC's Annika Kim Constantino contributed to this report. It's a dynamic GoodRx deems "the big pinch." High medication costs are coupled with reduced insurance coverage. Analyzing coverage for ove ...

GoodRx aims to give consumers a better handle on prescription affordability. High costs are a barrier for consumers seeking all sorts of healthcare beyond prescription drugs. In some cases, costs may have nothing to do with the medical field. "A multitude of health-related issues can cascade from there," PYMNTS reported this week. "Women who lack reliable transportation are 17% less likely to get the preventive medical care they need. Compared to those with access to transportation, they are also 78% more l ...

CONTACT US HERE: WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of ...

RADNOR, Pa., June 19, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against GoodRx Holdings, Inc. (NASDAQ: GDRX) ("GoodRx" or the "Company") on behalf of investors who purchased or acquired GoodRx common stock between September 23, 2020, and November 8, 2022, inclusive (the "Class Period"). This action, captioned Barsuli v. GoodRx Holdings, Inc., et al., Case No. Case 2:24-cv-03282- DDP-AJR was fi ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 8, 2022, both dates inclusive (the "Class Period"), of the important June 21, 2024 lead plaintiff deadline. To join the GoodRx class action, go to https://rosenlegal.com/submit-form/?case_id=24355 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. Contact Information: NEW Y ...

If you suffered substantial losses and wish to serve as lead plaintiff of the GoodRx class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449- 4900 or via e-mail at info@rgrdlaw.com. Lead plaintiff motions for the GoodRx class action lawsuit must be filed with the court no later than June 21, 2024. The GoodRx class action lawsuit alleges that defendants throughout the Class Period made false and/or mi ...

NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX). Shareholders who purchased shares of GDRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: DEADLINE: June 21, 2024 Shareholders should not delay in registering for this class action. Register your information ...